SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-17-008851
Filing Date
2017-11-13
Accepted
2017-11-13 16:10:02
Documents
119
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bgne-20170930x10q.htm 10-Q 2665075
2 EX-10.2 bgne-20170930ex102ea32c8.htm EX-10.2 977294
3 EX-10.3 bgne-20170930ex103fa0c22.htm EX-10.3 398072
4 EX-10.4 bgne-20170930ex1045205eb.htm EX-10.4 5764
5 EX-10.5 bgne-20170930ex1059f04ad.htm EX-10.5 287758
6 EX-31.1 bgne-20170930ex311489306.htm EX-31.1 21800
7 EX-31.2 bgne-20170930ex31299710a.htm EX-31.2 21214
8 EX-32.1 bgne-20170930ex32134f91b.htm EX-32.1 13605
  Complete submission text file 0001558370-17-008851.txt   11031731

Data Files

Seq Description Document Type Size
9 EX-101.INS bgne-20170930.xml EX-101.INS 1776359
10 EX-101.SCH bgne-20170930.xsd EX-101.SCH 84421
11 EX-101.CAL bgne-20170930_cal.xml EX-101.CAL 104833
12 EX-101.DEF bgne-20170930_def.xml EX-101.DEF 241179
13 EX-101.LAB bgne-20170930_lab.xml EX-101.LAB 627254
14 EX-101.PRE bgne-20170930_pre.xml EX-101.PRE 532495
Mailing Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT OZANNES CORPORATE SERVICES 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37686 | Film No.: 171195917
SIC: 2834 Pharmaceutical Preparations